FOLH1 and prostate carcinoma: Moreover, a meta-analysis of recent studies has confirmed the excellent sensitivity and specificity of PSMA PET in detecting prostate cancer and its high impact on patient management and clinical decision-making, especially in biochemical recurrence [8].